Immunomodulation of peritoneal macrophages by granulocyte-macrophage colony-stimulating factor in humans

This publication has 40 references indexed in Scilit:

• Commercial dialysate inhibits TNFα mRNA expression and NF-κB DNA-binding activity in LPS-stimulated macrophages
  Kidney International, 1995
• The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
  New England Journal of Medicine, 1995
• Different membrane expression of CD11b and CD 14 on blood neutrophils following in vivo administration of myeloid growth factors
  British Journal of Haematology, 1993
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
  New England Journal of Medicine, 1992
• Expression of transferrin receptors by monocytes and peritoneal macrophages from renal failure patients treated by continuous ambulatory peritoneal dialysis (CAPD)
  European Journal of Clinical Investigation, 1991
• Control of Granulocytes and Macrophages: Molecular, Cellular, and Clinical Aspects
  Science, 1991
• Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls
  Clinical Immunology and Immunopathology, 1990
• Hematopoietic Growth Factors
  New England Journal of Medicine, 1989
• Multiple actions of interleukin 6 within a cytokine network
  Immunology Today, 1988
• Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.
  The Journal of Experimental Medicine, 1987